Literature DB >> 10329585

Mapping of genetic deletions on the long arm of chromosome 4 in human esophageal adenocarcinomas.

C A Rumpel1, S M Powell, C A Moskaluk.   

Abstract

Loss of the long arm of chromosome 4 has been identified previously as a common occurrence in adenocarcinomas of the esophagus and gastroesophageal junction by relatively low resolution genetic surveys. To better define the extent of 4q deletion in these neoplasms we isolated DNA from 29 primary carcinomas using microdissection, and used DNA obtained from xenografts of 14 carcinomas grown in immunodeficient mice in an assay of loss of heterozygosity of 25 polymorphic microsatellite markers distributed along the chromosomal arm. Two carcinomas exhibited widespread microsatellite instability and were excluded from deletion mapping. In the remaining 41 carcinomas, loss of heterozygosity was detected in 33 (80%). Twenty-three cancers showed complete or extensive reduction to homozygosity along the length of the long arm. Ten cancers had smaller discrete areas of loss and were principally useful in discerning three non-overlapping areas of consensus genetic deletion. Area 1 centered on marker D4S1534 at 4q21.1-22, area 2 centered on marker D4S620 at 4q32-33, and area 3 centered on marker D4S426 at 4q35. No known tumor suppressor genes map to these loci, but the frequent deletion of these areas in gastroesophageal carcinomas and in other carcinomas suggests that undiscovered tumor suppressor genes may reside here.

Entities:  

Mesh:

Year:  1999        PMID: 10329585      PMCID: PMC1866588          DOI: 10.1016/S0002-9440(10)65386-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma.

Authors:  G M Hampton; A A Larson; R N Baergen; R L Sommers; S Kern; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Laser capture microdissection.

Authors:  M R Emmert-Buck; R F Bonner; P D Smith; R F Chuaqui; Z Zhuang; S R Goldstein; R A Weiss; L A Liotta
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

3.  Positional cloning of the gene for multiple endocrine neoplasia-type 1.

Authors:  S C Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; F S Collins; M R Emmert-Buck; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; J S Crabtree; Y Wang; B A Roe; J Weisemann; M S Boguski; S K Agarwal; M B Kester; Y S Kim; C Heppner; Q Dong; A M Spiegel; A L Burns; S J Marx
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

4.  Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

Authors:  M Tirkkonen; O Johannsson; B A Agnarsson; H Olsson; S Ingvarsson; R Karhu; M Tanner; J Isola; R B Barkardottir; A Borg; O P Kallioniemi
Journal:  Cancer Res       Date:  1997-04-01       Impact factor: 12.701

5.  Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers.

Authors:  S Thiagalingam; C Lengauer; F S Leach; M Schutte; S A Hahn; J Overhauser; J K Willson; S Markowitz; S R Hamilton; S E Kern; K W Kinzler; B Vogelstein
Journal:  Nat Genet       Date:  1996-07       Impact factor: 38.330

6.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

7.  MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.

Authors:  K Eppert; S W Scherer; H Ozcelik; R Pirone; P Hoodless; H Kim; L C Tsui; B Bapat; S Gallinger; I L Andrulis; G H Thomsen; J L Wrana; L Attisano
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

8.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

9.  Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4.

Authors:  Z T Hammoud; Z Kaleem; J D Cooper; R S Sundaresan; G A Patterson; P J Goodfellow
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

10.  Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers.

Authors:  Y Huang; R F Boynton; P L Blount; R J Silverstein; J Yin; Y Tong; T K McDaniel; C Newkirk; J H Resau; R Sridhara; B J Reid; S J Meltzer
Journal:  Cancer Res       Date:  1992-12-01       Impact factor: 12.701

View more
  13 in total

1.  Coculturing diverse clonal populations prevents the early-stage neoplastic progression that occurs in the separate clones.

Authors:  M Chow; H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 2.  Molecular biology of Barrett's adenocarcinoma.

Authors:  B P Wijnhoven; H W Tilanus; W N Dinjens
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

3.  A mortality gene(s) for the human adenocarcinoma line HeLa maps to a 130-kb region of human chromosome 4q22-q23.

Authors:  Steven D Bryce; Vivienne Morrison; Nicola J Craig; Nicholas R Forsyth; Sara A Fitzsimmons; Hazel Ireland; Andrew P Cuthbert; Robert F Newbold; E Kenneth Parkinson
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

4.  Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions.

Authors:  H van Dekken; J C Alers; P H Riegman; C Rosenberg; H W Tilanus; K Vissers
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

5.  Novel DNA copy number losses in chromosome 12q12--q13 in adenoid cystic carcinoma.

Authors:  W El-Rifai; S Rutherford; S Knuutila; H F Frierson; C A Moskaluk
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

6.  Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence.

Authors:  A K Walch; H F Zitzelsberger; J Bruch; G Keller; D Angermeier; M M Aubele; J Mueller; H Stein; H Braselmann; J R Siewert; H Höfler; M Werner
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  Tumor suppress genes screening analysis on 4q in sporadic colorectal carcinoma.

Authors:  Li-Xin Jiang; Jie Xu; Zhao-Wen Wang; Da-Peng Li; Zhi-Hai Peng; Jian-Jun Gao; Lin He; Hai-Tao Zheng
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

8.  Genetic alterations in primary gastric carcinomas correlated with clinicopathological variables by array comparative genomic hybridization.

Authors:  Ji Un Kang; Jason Jongho Kang; Kye Chul Kwon; Jong Woo Park; Tae Eun Jeong; Seung Mu Noh; Sun Hoe Koo
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

9.  Alternative splicing of the FGF antisense gene: differential subcellular localization in human tissues and esophageal adenocarcinoma.

Authors:  Shuo Cheng Zhang; Christie Barclay; Leigh Ann Alexander; Laurette Geldenhuys; Geoffrey A Porter; Alan G Casson; Paul R Murphy
Journal:  J Mol Med (Berl)       Date:  2007-06-14       Impact factor: 4.599

10.  Microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia-adenocarcinoma sequence.

Authors:  Jian-Chun Cai; Di Liu; Kai-Hua Liu; Hai-Ping Zhang; Shan Zhong; Ning-Sao Xia
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.